AMP-PCR DNA methylation assay for crop trait analysis in horse gram

Overview

This solution offers a validated molecular assay for detecting and quantifying DNA methylation variation in horse gram (Macrotyloma uniflorum), a legume crop. The technology addresses a key gap in crop genetics: economically important traits such as growth habit cannot always be explained by DNA sequence variation alone. By combining genetic and epigenetic analysis, the AMP-PCR assay enables researchers and breeders to uncover methylation-based markers associated with agronomically valuable characteristics. The approach is particularly relevant for breeding programs targeting trait selection, germplasm characterization, and the development of improved crop varieties.

Technical specifications

Core methodology:

• Uses AMP-PCR with two isoschizomer restriction enzymes (MspI and HpaII) that recognize the same tetra-nucleotide sequence but differ in sensitivity to DNA methylation
• Enables detection and quantification of four DNA methylation types: external, internal, full, and non-methylation
• Employs RAPD primers containing MspI/HpaII recognition sequences for selective amplification

Experimental design:

• Applied across three developmental stages: seedling, tendril initiation, and flowering
• Uses eight pairs of isogenic lines differing only in growth habit to control for background genetic variation
• Genomic DNA digested separately with MspI, HpaII, and a combination of both, alongside controls

Key features:

• Standardized protocol optimized for horse gram genome
• Proven applicability in related legume species (validated in dolichos bean)
• Significant association demonstrated between detected methylation polymorphism and economically important traits

Technology readiness level

The AMP-PCR protocol has been standardized in the laboratory and validated in dolichos bean, where DNA methylation variation was found to be significantly associated with economically important traits. Isogenic lines of horse gram have been identified for further validation. The next phase involves completing AMP-PCR assays across multiple developmental stages in these isogenic lines to confirm methylation-trait associations. The technology is at an early-to-mid stage of development (TRL 3-4), with demonstrated proof-of-concept in a related species and a clear validation pathway in the target crop.